Heterogeneity/NN
of/IN
clonal/JJ
development/NN
in/IN
chronic/JJ
myeloproliferative/JJ
disorders/NNS
./.

Recent/JJ
reports/NNS
have/VBP
suggested/VBN
a/DT
previously/RB
unexpected/JJ
variability/NN
in/IN
the/DT
expression/NN
of/IN
the/DT
dominant/JJ
neoplastic/JJ
clone/NN
in/IN
myeloproliferative/JJ
disorders/NNS
(/(
MPD/NN
)/)
./.
=====
We/PRP
evaluated/VBD
49/CD
female/JJ
patients/NNS
with/IN
MPD/NN
and/CC
informative/JJ
at/IN
the/DT
X-linked/JJ
androgen/NN
receptor/NN
(/(
AR/NNS
)/)
locus/NN
to/TO
establish/VB
the/DT
X/NN
chromosome/NN
inactivation/NN
pattern/NN
of/IN
hemopoietic/JJ
cells/NNS
./.
=====
Whereas/IN
in/IN
chronic/JJ
myelogenous/JJ
leukemia/NN
(/(
CML/NN
)/)
the/DT
granulocytes/NNS
(/(
PMN/NN
)/)
were/VBD
uniformly/RB
of/IN
monoclonal/JJ
origin/NN
,/,
a/DT
striking/JJ
heterogeneity/NN
of/IN
clonal/JJ
development/NN
was/VBD
found/VBN
in/IN
PMN/NN
from/IN
patients/NNS
with/IN
other/JJ
MPD/NN
,/,
with/IN
up/IN
to/TO
50/CD
%/NN
of/IN
them/PRP
expressing/VBG
a/DT
polyclonal/JJ
pattern/NN
of/IN
X/NN
inactivation/NN
./.